These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 32432400

  • 21. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM.
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 23. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Israelyan N, Vege S, Friedman DF, Zhang Z, Uter S, Fasano RM, Yee M, Piccone C, Kelly S, Hankins JS, Zheng Y, Westhoff CM, Chou ST.
    Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184
    [Abstract] [Full Text] [Related]

  • 24. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM, Chou ST.
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [Abstract] [Full Text] [Related]

  • 25. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
    Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR.
    Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
    [Abstract] [Full Text] [Related]

  • 26. Extended red blood cell matching for all transfusion recipients is feasible.
    van Sambeeck JHJ, van der Schoot CE, van Dijk NM, Schonewille H, Janssen MP.
    Transfus Med; 2022 Jun; 32(3):221-228. PubMed ID: 34845765
    [Abstract] [Full Text] [Related]

  • 27. Comparison of serology and molecular detection of common red cell antigens in multitransfused thalassemia major and sickle cell disease patients.
    Shah A, Patel P, Patel K, Patel B, Jariwala K, Sharma P, Mishra K, Ghosh K.
    Transfus Apher Sci; 2020 Feb; 59(1):102599. PubMed ID: 31326292
    [Abstract] [Full Text] [Related]

  • 28. Duffy blood group genotyping in Thai blood donors.
    Nathalang O, Intharanut K, Siriphanthong K, Nathalang S, Kupatawintu P.
    Ann Lab Med; 2015 Nov; 35(6):618-23. PubMed ID: 26354350
    [Abstract] [Full Text] [Related]

  • 29. Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units.
    Le Gallo M, Moutereau S, Gentil M, Pirenne F.
    Transfus Clin Biol; 2024 Aug; 31(3):130-134. PubMed ID: 38462030
    [Abstract] [Full Text] [Related]

  • 30. Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study.
    Meshi AA, Abu-Tawil H, Hamzi AA, Madkhali BA, Maghfori AB, Alnami II, Hamali HA, Madkhali MM.
    Int J Gen Med; 2024 Aug; 17():2855-2864. PubMed ID: 38947563
    [Abstract] [Full Text] [Related]

  • 31. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.
    Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG.
    Lancet Haematol; 2016 Jun; 3(6):e284-92. PubMed ID: 27264038
    [Abstract] [Full Text] [Related]

  • 32. Application of blood group genotyping in complex cases of immunohematology.
    Musial LB, Prochaska CL, Moss MF, Cruz BR.
    Asian J Transfus Sci; 2023 Jun; 17(2):164-168. PubMed ID: 38274970
    [Abstract] [Full Text] [Related]

  • 33. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease.
    Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ.
    Transfusion; 2008 May; 48(5):917-24. PubMed ID: 18248572
    [Abstract] [Full Text] [Related]

  • 34. HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease.
    Bernit E, Jean E, Marlot B, Laget L, Izard C, Dettori I, Beley S, Gautier I, Agouti I, Frassati C, Pedini P, Picard C, Paganini J, Chiaroni J, Di Cristofaro J.
    Int J Mol Sci; 2023 Sep 02; 24(17):. PubMed ID: 37686397
    [Abstract] [Full Text] [Related]

  • 35. [Contribution of red blood group genotyping for recipients in immune-hematology through three years of activity at the EFS Alpes-Méditerranée].
    Silvy M, Filosa L, Chiaroni J, Bailly P.
    Transfus Clin Biol; 2014 Dec 02; 21(6):289-95. PubMed ID: 25443328
    [Abstract] [Full Text] [Related]

  • 36. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S, Westhoff CM, Friedman DF, Chou ST.
    Transfusion; 2019 Jul 02; 59(7):2282-2291. PubMed ID: 31021439
    [Abstract] [Full Text] [Related]

  • 37. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille H.
    Transfusion; 2019 Jun 02; 59(6):2016-2022. PubMed ID: 30758856
    [Abstract] [Full Text] [Related]

  • 38. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
    Kambale-Kombi P, Djang'eing'a RM, Alworong'a Opara JP, Minon JM, Sepulchre E, Bours V, Floch A, Pirenne F, Tshilumba CK, Batina-Agasa S.
    Transfus Med; 2023 Apr 02; 33(2):137-146. PubMed ID: 36377544
    [Abstract] [Full Text] [Related]

  • 39. Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients.
    Eftekhar Z, Oodi A, Amirizadeh N, Mohammadipour M, Keikhaei Dehdezi B, Jalali Far MA.
    Expert Rev Clin Immunol; 2024 Nov 02; 20(11):1421-1426. PubMed ID: 39105247
    [Abstract] [Full Text] [Related]

  • 40. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Transfusion; 2013 Apr 02; 53(4):704-9. PubMed ID: 22804353
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.